Deutsche Beteiligungs AG to Invest in Hipp Technology Group

Deutsche Beteiligungs AG (DBAG) announces its investment in Hipp Technology Group, a leader in medical technology manufacturing. DBAG Fund VIII, advised by DBAG, will acquire a majority stake in Hipp. This transaction, facilitated by a management buyout, includes contributions from Markus Hipp, the company's founder and CEO, who retains a significant share.

Hipp specializes in producing advanced surgical instruments and implantology products for dental and orthopaedic applications. The company is recognized for its high-precision components used in various high-tech sectors, including aerospace and semiconductors.

DBAG's strategy aligns with Hipp's long-term growth prospects, driven by increasing market demand for orthopaedic implants. This investment marks the sixth DBAG transaction within eight months, underscoring DBAG's focus on resilient, high-growth businesses in the healthcare sector.